SCHEMBL5829487

SCHEMBL5829487

CN1CCN(c2nn(-c3ccccc3)cc2-c2ccncc2)CC1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.51
KDM4E B2RXH2 4/20 0.51
LMNA P02545 1/20 0.51
TSHR P16473 1/20 0.51
MAPK1 P28482 1/20 0.51
MAPK14 Q16539 3/20 0.50
CSNK1D P48730 2/20 0.50
MELK Q14680 2/20 0.50
BRAF P15056 2/20 0.47
PTGS2 P35354 2/20 0.44
HTT P42858 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
KMT2A Q03164 2/20 0.43
HSD17B10 Q99714 2/20 0.43
HPGD P15428 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
MAPK11 Q15759 1/20 0.43
NPSR1 Q6W5P4 1/20 0.42
HRH4 Q9H3N8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7248577 0.87 MAPK14 (0.52) ALDH1A1KDM4ELMNATSHRMAPK1
SCHEMBL6337994 0.87 MELK (0.51) MAPK14CSNK1DMELKBRAFPTGS2
SCHEMBL7148386 0.75 GRM4 (0.55) ALDH1A1KDM4ELMNAMAPK1MAPK14
SCHEMBL1753041 0.73 CSNK1D (0.60) ALDH1A1KDM4ELMNATSHRMAPK1
SCHEMBL17619706 0.72 PTGS2 (0.51) ALDH1A1KDM4ELMNAMAPK14BRAF
SCHEMBL5829519 0.72 CYP17A1 (0.51) ALDH1A1TSHRMAPK1MAPK14KMT2A
SCHEMBL5463406 0.71 ROCK2 (0.44) ALDH1A1KDM4ELMNATSHRMAPK1
SCHEMBL7250809 0.69 AKR1C3 (0.46) ALDH1A1BRAFSMN1; SMN2KMT2AL3MBTL1
Ammonia Solution, Strong SCHEMBL5740005 0.69 ADRA2C (0.50) KMT2A
SCHEMBL28337260 0.68 MELK (0.69) ALDH1A1KDM4EMELKSMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7071198-B1 Antiinflamamtory agents; antiarthritic agents; inflammatory bowel disorders; multiple sclerosis; asthma PHARMACIA CORPORATION (US) 2006-07-04 US disclosed